Mike Ryan Executive Vice President at Eversana shares a glimpse of his upcoming panel discussion at the Reuters Pharma 2025 event on “28 countries for 2 years: Explore and evaluate the trade-offs in European launch sequencing”
Mike elaborates on Eversana’s comprehensive offerings that help biopharmaceutical companies tap into the complex European market. He highlights the challenges facing the biopharma companies while navigating the regulatory landscape and HTAs standards set by the European countries.
By unlocking the infrastructure, including market access and pricing strategies, biopharma companies can seamlessly become commercial powerhouses.
Image Source: Canva
About the Author:
Mike Ryan
Related Post: Reuters Pharma 2025: Pre-Conference Talks Featuring Nazneen Rahman
